Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01056861 · ClinicalTrials.gov registry record
Effects of Botulinum Toxin in Cervical Dystonia
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 7
- Enrollment target
NCT01056861 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 7 participants.
The verdict
NCT01056861 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Botulinum toxin injection in the contracting muscles has proven to be a safe and effective method of relieving pain and lessening dystonic posturing. The current hypothesis is that botulinum toxin works on altering sensory input in the central nervous system in addition to its effects on the neuromuscular junction. Magnetoencephalography (MEG)of brain has been used in dystonia such as writer's cramp and musician's hand dystonia. However, no study has investigated the correlation of central signal changes via magnetoencephalography before and after treatment with botulinum in torticollis patients. Prior studies using somatosensory potentials indicated the possibility of differential activation of precentral cortex in patients with cervical dystonia. Cervical dystonia may result from a disorder of both cortical excitability and intracortical inhibition. The investigators hypothesis is that botulinum injection modulates central inhibition which improves clinical outcome for torticollis.
Interventions
- DRUG Botulinum Toxin A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01056861
The ClinicalTrials.gov registry entry for NCT01056861 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Botulinum Toxin A is the first listed.
NCT01056861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01056861 about?
NCT01056861 is a clinical study titled "Effects of Botulinum Toxin in Cervical Dystonia". Botulinum toxin injection in the contracting muscles has proven to be a safe and effective method of relieving pain and lessening dystonic posturing. The current hypothesis is that botulinum toxin works on altering sensory input in the central nervous system in addition to its effects on the neuromu...
What is the current status of trial NCT01056861?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2010-01. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01056861?
The interventions under investigation include: Botulinum Toxin A (DRUG).
Who is sponsoring clinical trial NCT01056861?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.